Multifunctional Anti-Amyloid Peptides

Aberrant amyloid self-assembly and cytotoxicity of Aß and a-Synuclein are linked to the pathogenesis of more than 50 cell-and neurodegenerative diseases including Alzheimer's (AD), Parkinson’s disease (PD) and type 2 diabetes (T2D), the latter being epidemiologically linked to both AD and PD. For this reason, there is an urgent need to develop molecules that suppress both amyloid self-assembly and cross-seeding interactions of above peptides can be promising leads for therapeutics in AD, PD and T2D.
Life Sciences
Therapeutics
Reference
b84076
IP right year
2025
IP status
PCT phase initiated
Patentee
Technical University of Munich
Contact
Charlotte Federhen

Challenge and innovation

AD-and PD-related neurodegeneration in the brain are linked to the self-assembly of Aß and a-Synuclein while T2D-related pancreatic beta-cell degeneration is linked with amyloid self-assembly of IAPP. Cross-seeding interactions between different amyloid polypeptides/proteins have emerged as possible molecular links between various different cell-/neurodegenerative diseases. Molecules that suppress both amyloid self-assembly and cross-seeding are urgently needed, however.

The results suggest that the anti-amyloid function of MCIP 2 b and 2 e is mediated via interactions with αSyn via three αSyn segments identified as key sites of both αSyn self- and its cross-interactions with IAPP. MCIP 2b and 2 e are also able to block Aβ42-mediated cross-seeding of αSyn. Based on their broad spectrum amyloid inhibitor activity and additional drug-like properties, MCIPs are promising leads for multifunctional anti-amyloid drugs in PD, T2D, AD, and their comorbidities. The identified key αSyn segments shall serve as valuable targets for the design of novel, multi-site targeting molecules as effective anti-amyloids in PD and related synucleinopathies.

Talk to an expert

Interested in learning more about this technology offer, exploring potential applications or discussing a possible collaboration? Get in touch to learn more.